pocketful logo light
pocketful logo light
Makers Laboratories Ltd logo

Makers Laboratories Ltd

NSE: BSE: 506919

161

(8.76%)

Sat, 30 May 2026, 05:32 pm

Makers Laboratories Share Price Live Chart

1 Day

(8.76%)

No Result Found

Summary

  • Market Cap

    96.62

  • Net Profit

    10.91

  • P/B

    1.08

  • Sector P/E

    34.30

  • P/E

    10.16

  • EV/EBITDA

    4.27

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    4.90

  • ROCE

    6.43

  • Debt/Equity

    0.22

  • EPS (TTM)

    3.99

  • Dividend Yield

    0

  • Book Value

    123.59

  • Interest Cover

    4.11

Analysis

all

thumbs up icon

Pros

  • Makers Laboratories's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Makers Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Makers Laboratories has been profitable on average in the past, therefore cash runway is not a concern.
  • Makers Laboratories has been profitable on average in the past, therefore cash runway is not a concern.
  • Debt is well covered by operating cash flow (29.6%, greater than 20% of total debt).
thumbs up icon

Cons

  • No dividend growth in 10 years.
  • The company is paying a dividend however it is incurring a loss.
  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Makers Laboratories's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • The level of debt compared to net worth has increased over the past 5 years (3.2% vs 19.1% today).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters61.2761.2761.2761.2761.27
FII00000
DII0.390.390.390.390.39
Public38.3438.3438.3438.3438.34
Government00000

Read More

Technical Analysis

RSI

54.65

MACD

3.80

50 DMA

154.71

200 DMA

138.13

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic221.27183.92162.48146.57125.13109.2271.87
Fibonacci183.92169.65160.83146.57132.30123.48109.22
Camarilla151.32147.90144.47146.57137.63134.20130.78

Pivots Level: Classic

R3

+74.70

221.27

R2

+37.35

183.92

R1

+15.92

162.48

146.57
146.57
Pivot Point
LTP: 163.75

S1

-21.43

125.13

S2

-37.35

109.22

S3

-74.70

71.87

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    163.22

  • 20-EMA

    160.16

  • 30-EMA

    157.89

  • 50-EMA

    154.09

  • 100-EMA

    147.44

  • 200-EMA

    143.52

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
26 May 2026board-meetingsQuarterly Results
10 Feb 2026board-meetingsQuarterly Results
07 Nov 2025board-meetingsQuarterly Results
02 Jul 2025agm
10 Jul 2024agm
11 Jul 2023agm
15 Jul 2022agm
29 Mar 2022rights1:5 Rights Issue of Equity Shares01 Apr 2022
01 Mar 2022rightsRight Issue of Equity Shares01 Apr 2022
19 Jul 2021agm

Read More

Peer Comparison

Makers Laboratories Ltd logo

Makers Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Makers Laboratories Ltd About

Makers Laboratories is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company has one manufacturing unit in India manufacturing formulations for the Indian market.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1984

Headquarters

CEO

R K P Verma

Employees

Contact

Website icon

Website

http://www.makerslabs.com

Email icon

Email

investors@makerslabs.com; makers@makerslabs.com

Phone icon

Phone

91-22-2868 8544

Location icon

Location

54 D Kandivli Industrial Estat, Charkop Kandivli (West), Mumbai, Maharashtra, 400067

Read More

Makers Laboratories Ltd Company History

YearHistory
1993
  • Makers Drugs & Food Products Ltd. was amalgamated with the company.
  • The company allotted 3,02,700 equity shares to the members of MDFPL in the ratio of 2:1.
2006
  • Mrs Purnima Jain was appointed as an Additional Director and Whole-time Director of the company.
2010
  • The board recommended a dividend of 10%.
2011
  • The company recommended a dividend of Re. 1/- per share (10%).
2022
  • The company issued rights shares of Rs. 10 in the ratio of 1:5 at a premium of Rs. 140 per share.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
USHA JAWAHARLAL KALRObulkSell26158180.2520 May 2026
USHA JAWAHARLAL KALRObulkBuy31009173.2720 May 2026
MANJU SINGHIbulkSell29562105.7513 Mar 2023
VARA LAKSHMI GbulkSell59149139.523 Nov 2020
VINAR NIRYAT PRIVATE LIMITEDbulkBuy46250138.7623 Nov 2020
NEELIMA KARLAPUDIbulkSell5023696.906 Oct 2020
USHA ASHOK SAMANIbulkBuy3000072.712 Aug 2020
GUTTIKONDA VARA LAKSHMIbulkSell2499179.2303 Aug 2020
NANDA DEVI INVESTMENTSbulkSell2597739.9508 Apr 2020
GUTTIKONDA VARA LAKSHMIbulkBuy3077199.0421 Sept 2018

Read More

Makers Laboratories Ltd News

Makers Labs FY26 consolidated profit falls 78%

Makers Laboratories reported a 78.5% drop in consolidated net profit to ₹235.13 lakh for FY26. Revenue rose 16.4% to ₹14,059.48 lakh.

26 May 2026

companies

Makers Laboratories Board Meet on May 26 for Q4FY26 Results

Makers Laboratories has scheduled a Board of Directors meeting on May 26, 2026, to consider audited financial results for Q4 and full year ended March 31, 2026.

05 May 2026

companies

Makers Laboratories Submits Q4FY26 SEBI Compliance Certificate

Makers Laboratories Limited filed its quarterly certificate under SEBI Regulation 74(5) for Q4FY26, confirming compliance with dematerialisation requirements through registrar MUFG Intime India.

06 Apr 2026

companies

Makers Laboratories Q3FY26 Revenue Jumps 28.8% YoY

Makers Laboratories Limited reported consolidated revenue of ₹3,566.76 lakhs for Q3FY26, up 28.8% YoY. Nine-month revenue reached ₹10,484.31 lakhs, marking 20.7% growth over previous year.

11 Feb 2026

co actions results

Makers Laboratories Board Meet on Feb 10 for Q3 Results

Makers Laboratories Limited has scheduled its Board of Directors meeting for February 10, 2026, to consider and approve Q3FY26 unaudited financial results. Trading window remains closed until February 12.

21 Jan 2026

co actions results

Read More